Liping Liu is the founder of Jun Shengtai. Latest round: IPO. Backed by UBS, Huatai International.
Liping Liu is the Founder, Chair, CEO, and Chief Scientific Officer (CSO) of High Tide Therapeutics (also known as Junshengtai Biotechnology Co., Ltd.), a globally integrated biopharmaceutical company. The company submitted an IPO application to the main board of the Hong Kong Stock Exchange on May 30.
Full founder directory · Investor directory · Company funding database · Fundraising library